Research & Development
Cancer: Page 5
AccuStem Sciences and EmeritusDX team up on breast cancer assay, product portfolio
Initially, the partnership will focus on furthering the validation of StemPrintER, AccuStem’s recurrence predictor assay for patients with breast cancer.
July 19, 2023
Quest launches biomarker test to improve grading of prostate cancer biopsies
Building on the Australian research and working with Envision Sciences, the Australian diagnostics company that owns the biomarker intellectual property, Quest’s subspecialty pathology business, AmeriPath, has developed a tissue-based test.
July 17, 2023
Epigenetic study links DNA methylation to diseases including breast cancer and diabetes
Through the analysis, the researchers identified 69 associations between CpGs and the prevalence of breast cancer, chronic kidney disease, ischemic heart disease, and type 2 diabetes. The majority of the associations had not previously been described.
July 12, 2023
Pfizer invests $25M to support development of CellCentric’s blood cancer candidate
Evidence of the roles p300 and CBP play in multiple cancers led CellCentric to generate chemical hits against the proteins, ultimately leading to the development of inobrodib.
July 13, 2023
Cancer detection firm Elypta awarded quality certification
The scope of the certification includes the design and development of in vitro diagnostic (IVD) test kits and software for Elypta’s liquid biopsy-based platform for the detection and measurement of glycosaminoglycans (GAGomes) across different cancers.
July 7, 2023
Castle Biosciences reports study validation for melanoma gene expression test
The study findings support results from a recently published study which showed that patients who received routine imaging guided by high-risk 31-GEP test scores had earlier diagnoses of recurrence, which in turn led to better outcomes for patients.
July 6, 2023
LAMH receives Chinese approval for blood test designed to accelerate liver cancer diagnosis
The test was based on the multianalyte blood test HelioLiver, developed by Helio Genomics, and adapted for the genetics of the Asia-Pacific population, resulting in a product that could help address a major healthcare challenge in China.
July 5, 2023
DermTech moves to lay off 40 people, focuses on melanoma test to reduce spending
DermTech is reducing its workforce by 15% as part of a restructuring that will see the company suspend pipeline programs and focus on growing sales of its DMT melanoma test.
June 30, 2023
Genomics AI firm Genomenon acquires Boston Genetics
An expanded genomic interpretation team enabled by the acquisition supports its offerings for clinical diagnostic and pharmaceutical drug development programs, Genomenon said.
June 27, 2023
President Biden launches $50M initiative to improve cancer outcomes in low-income areas
The award creates five Centers for Cancer Control Research in Persistent Poverty Areas to advance key priorities of the Administration’s Cancer Moonshot.
June 26, 2023
Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology
Multiplex imaging technology enables the integration of microscopic analysis with the visualization of molecular markers in individual cells.
June 26, 2023
Gene mutations linked to drug-resistant liver cancer
Certain gene mutations could help physicians predict which hepatocellular carcinoma patients are most likely to develop drug resistance to lenvatinib.
June 26, 2023
Page 5 of 93